Venous Thromboembolism-1

Slides:



Advertisements
Similar presentations
Chapter 12 Disorders of Hemostasis
Advertisements

Haemostasis Prof. K. Sivapalan.
Section 3 Thrombosis Definition: Thrombosis is the formation of a blood clot within the vascular system during life. The blood clot is adherent to the.
Thrombosis Dr Aarathi Rau. Hemostasis Normal hemostasis: the end result of a set of well regulated processes that accomplish fluid blood in the normal.
An Overview of Hemostasis
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
Haemostasis and NovoSeven®
PLATELETS (PLT) Thrombocytes. PLATELETS (PLT) Thrombocytes.
HEMOSTASIS Hemostasis
Hemostasis.
CHAPTER13 Biomaterials and Thrombosis 13-1 Introduction: Overview of Hemostasis Blood-Biomaterials Interaction via protein coats ---- blood coagulation.
Blood Clotting Robin Gray.
Coagulation Just the basics.... Three steps Vasoconstriction Platelet plug formation Fibrin clot formation.
From Blood to Host Defense Hemostasis and Clotting
Pathology 430/826 Thrombosis David Lillicrap. Cardiovascular Disease 30% of all deaths in Canada 54% ischemic heart disease 20% stroke 23% heart attack.
MLAB Coagulation Keri Brophy-Martinez
Asilmi HEMOSTASIS Ahmad Shihada Silmi Faculty of Sciences IUG Med. Tech. Dep. Room # B326.
Blood S-J Tsai Department of Physiology. Composition Composed of cells (erythrocytes, leukocytes, and platelets) and plasma (the liquid in which the cells.
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
HMIM BLOCK 224 PLATELET AND HEMOSTASIS Dr. Zahoor Lecture - 6.
Hemodynamic Disorders (Disorders of blood flow)
HEMOSTASIS Primary hemostasis.
Scheme of Coagulation F XIIF XIIa F XIF XIa F IX F X F IXa F VIIaF VII Extrinsic System Tissue damage Release of tissue thromboplastine (F III) Intrinsic.
Haemostasis Presented by Dr Azza Serry. Learning Objectives  Definition.  Clotting mechanism.  What keeps blood in fluid status  Control of blood.
Blood Part 2. Hemostasis Responses that stop bleeding When blood vessels are damaged or ruptured, the hemostatic response must be quick, localized to.
Hemostasis Constriction of vessel Aggregation of platelets
Coagulation Mechanisms
THROMBOSIS Dr. Afsar Saeed Shaikh M.B.B.S, M.Phil. Assistant Professor of Chemical Pathology Pathology Department, KEMU, Lahore.
FLUID AND HEMODYNAMIC DERANGEMENTS - PART II
Clot Formation Review with Animations
Nerves Smooth muscle Endothelium Platelets White cells eg neutrophils Red cells.
Haemostasis Dr.Salah Elmalik Department of Physiology
Objectives At the end of this lecture student should be able to: 1.Recognize different stages of hemostasis 2.Describe formation and development.
HAEMOSTASIS & FIBRINOLYSIS
Von Willebrand Disease
Introduction to Haemostasis Ahmad Sh. Silmi Hematologist Msc,FIBMS.
Investigation of Haemostasis.. HHHHaemostasis is the arrest of blood loss from damaged vessels. TTTThe haemostatic mechanisms have two primary.
Coagulation and fibrinolysis
Hemodynamics 2.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 26 Disorders of Hemostasis.
Thrombosis and Haemostasis Café Cardiologique 29/10/2014.
Blood Plasma Plasma –Liquid part of blood –Clear, straw-colored fluid –90% water and 10% solutes –Solutes 6% to 8% of solutes are proteins –Albumins—helps.
بسم الله الرحمن الرحيم.
Blood Clotting In the absence of blood vessel damage, platelets are repelled from each other and from the endothelium of blood vessels. When a blood vessel.
Blood coagulation. Blood coagulation Blood coagulation Conversion of fluid state of blood into semisolid state by activation and interaction of pro-coagulants.
Platelets (Thrombocytes)
Hemodynamic Disorders 2
HAEMOSTASIS AND THROMBOSIS Regulation of coagulation
CLS 223.
Activation of the Hemostatic System During Cardiopulmonary Bypass
2nd Year Medicine- Blood Module May 2008
Hypercoagulable States
What is haemostasis? Coagulation Fibrinolysis
Drugs Used in Coagulation Disorders
Thrombosis and embolism
HEMOSTASIS BY: SATHISH RAJAMANI. ASSOCIATE PROFESSOR.
Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College
Hemodynamic disorders (1 of 3)
Figure 1 Mechanism of thrombus formation during ST-segment
UNIT 3 NOTES: Hematopoiesis & Hemostasis
Antithrombotic and prothrombotic molecules Content Points:
Drugs Affecting Blood.
Introduction to Haemostasis
THROMBOSIS.
Endothelial regulation: Understanding RAS
Hemostasis Hemostasis depends on the integrity of Blood vessels
Section B: Science update
Presentation transcript:

Venous Thromboembolism-1 Dr. Abdelaty Shawky Mohamed Assistant professor of pathology

* Topics: 1. Pathophysiology of VTE. 2. Clinical presentation of VTE. 3. Investigations of VTE.

1. Pathophysiology of VTE

Hemostasis and Thrombosis Hemostasis is the physiologic process that maintains the blood in a fluid state in normal vessels and to induce a rapid and localized hemostatic plug at a site of vascular injury to stop bleeding.

Thrombosis is the pathologic process opposite to hemostasis; it can be considered an inappropriate activation of normal hemostatic processes, resulting in the formation of a (thrombus) in uninjured vessel or after minor injury.

Both hemostasis and thrombosis are regulated by three general components. 1. The vascular endothelium. 2. Platelets. 3. The coagulation cascade.

Q. What is the role of endothelial cells in hemostasis and thrombosis?

Endothelial cells have both antithrombotic activities preventing thrombosis in normal blood vessel and also have prothrombotic activities favoring thrombosis in injured blood vessels. The balance between endothelial antithrombotic and prothrombotic activities critically determines whether thrombus formation, propagation, or dissolution occurs

* Antithrombotic Properties Antiplatelet effects: by secretion of prostacyclin (PGI2) and nitric oxide. Both mediators are potent vasodilators and inhibitors of platelet aggregation. Anticoagulant effects: These effects are mediated by; a. Thrombomodulin receptors for (thrombin) to block its action and also to activate protein C which in turn inactivate factors V and VIII. b. Heparin-like molecules: receptors for anti-thrombin III to block factors IX and X. c. Release of tissue factor inhibitor. These inhibit the coagulation pathway.

Fibrinolytic effects: Endothelial cells synthesize tissue-type plasminogen activator (t-PA), promoting fibrinolytic activity to clear fibrin deposits from endothelial surfaces .

* Prothrombotic Properties: Platelet effects: - Endothelial injury leads to adhesion of platelets to the underlying extracellular matrix; this is facilitated by endothelial production of von Willebrand factor (vWF), an essential cofactor for platelet binding to subendothelial collagen.

Procoagulant effects: Endothelial cells synthesize tissue factor, which activates the extrinsic clotting cascade. Antifibrinolytic effects: Endothelial cells also secrete inhibitors of plasminogen activator (PAIs), which inhibits fibrinolysis.

Coagulation cascade

Thrombosis

* Definition of thrombosis: - Formation of a solid mass composed of the circulating blood elements, inside CVS system (blood vessels or heart) during life.

* Causes of thrombosis: - There are 3 major factors which predispose to thrombosis (Virchow’s triad): 1. Endothelial damage. 2. Slowing & turbulence of blood flow. 3. Blood hypercoagulability.

1. Endothelial damage: - Endothelial damage may be: a. Mechanical: trauma, repeated tourniquet… b. Inflammatory: arteritis, phlebitis and endocarditis. c. Degenerative: atherosclerosis, hypertension.. - The injured endothelium becomes swollen with rough surface.

2. Slowing & turbulence of blood flow. - Occurs in; Left atrium in mitral stenosis. Leg veins in varicose veins and bed-ridden heart failure patients. Inside aneurysmal sacs.

3. Blood hypercoagulability: I. Genetic (inherited): Mutation of factor V gene. Mutation of prothrombin gene. - In both conditions; the resulting factor V and prothrombin are not prone to degradation and have a sustained thrombotic actions.

Protein C and protein S deficiency: These are natural anti-coagulant proteins. Their deficiency leads to hypercoagulability state.

II. Acquired: Prolonged bed rest or immobilization. Myocardial infarction. Tissue damage (surgery, fracture, burn). Cancer. Oral contraceptive pills.

* Pathogenesis (Mechanism) of thrombosis: Endothelial injury leads to: 1. Exposure of sub-endothelial collagen: promote platelet aggregation. 2. Release of tissue factor: promote fibrin formation.

I. Exposure of sub- endothelial collagen: a. Platelets adhesion to the exposed collagen (this is mediated by factor VIII released from endothelial cells). b. Platelet activation and release of Thromboxane A2 (potent vasoconstrictor and induce platelet aggregation)

II. Release of the tissue factor (from endothelial cells) that stimulate the coagulation cascade to form thrombin that convert fibrinogen into fibrin. The end result is fibrin network entangling aggregated platelet (Thrombus)

The lumen of blood vessel is occupied by a red mass which is adherent to the vessel wall at an area called the head of the thrombus .

Gross picture of the thrombus

Microscopic picture of thrombus:

These are "lines of Zahn" which are the alternating pale pink bands of platelets with fibrin and red bands of RBC's forming a true thrombus.

Thanks